These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1375 related items for PubMed ID: 15476679

  • 1. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC, Shih CM, Lai YH, Chen JH, Huang HL.
    Biochem Pharmacol; 2004 Nov 15; 68(10):2087-94. PubMed ID: 15476679
    [Abstract] [Full Text] [Related]

  • 2. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ, Cieslinski LB.
    Mol Pharmacol; 1990 Feb 15; 37(2):206-14. PubMed ID: 2154670
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I, Vandecasteele G, Lezoualc'h F, Fischmeister R.
    Br J Pharmacol; 1999 May 15; 127(1):65-74. PubMed ID: 10369457
    [Abstract] [Full Text] [Related]

  • 4. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):110-7. PubMed ID: 16458289
    [Abstract] [Full Text] [Related]

  • 5. Experimental studies on guanosine 3',5'-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265579 in guinea-pigs.
    Kapui Z, Schaeffer P, Mikus EG, Boronkay E, Gyürky J, Herbert JM, Pascal M.
    Arzneimittelforschung; 1999 Aug 08; 49(8):685-93. PubMed ID: 10483515
    [Abstract] [Full Text] [Related]

  • 6. Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity.
    Ahn HS, Bercovici A, Boykow G, Bronnenkant A, Chackalamannil S, Chow J, Cleven R, Cook J, Czarniecki M, Domalski C, Fawzi A, Green M, Gündes A, Ho G, Laudicina M, Lindo N, Ma K, Manna M, McKittrick B, Mirzai B, Nechuta T, Neustadt B, Puchalski C, Pula K, Zhang H.
    J Med Chem; 1997 Jul 04; 40(14):2196-210. PubMed ID: 9216839
    [Abstract] [Full Text] [Related]

  • 7. Differential inhibition of multiple cAMP phosphodiesterase isozymes by isoflavones and tyrphostins.
    Nichols MR, Morimoto BH.
    Mol Pharmacol; 2000 Apr 04; 57(4):738-45. PubMed ID: 10727520
    [Abstract] [Full Text] [Related]

  • 8. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.
    Cohan VL, Showell HJ, Fisher DA, Pazoles CJ, Watson JW, Turner CR, Cheng JB.
    J Pharmacol Exp Ther; 1996 Sep 04; 278(3):1356-61. PubMed ID: 8819523
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P, Prigent AF, Lagarde M, Nemoz G.
    Mol Pharmacol; 1993 Nov 04; 44(5):1027-35. PubMed ID: 8246905
    [Abstract] [Full Text] [Related]

  • 12. Characterization of renal ecto-phosphodiesterase.
    Jackson EK, Ren J, Zacharia LC, Mi Z.
    J Pharmacol Exp Ther; 2007 May 04; 321(2):810-5. PubMed ID: 17308037
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tyrosine kinase-independent inhibition of cyclic-AMP phosphodiesterase by genistein and tyrphostin 51.
    Nichols MR, Morimoto BH.
    Arch Biochem Biophys; 1999 Jun 15; 366(2):224-30. PubMed ID: 10356287
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ, Barnes PJ, Giembycz MA.
    Br J Pharmacol; 1998 May 15; 124(1):129-40. PubMed ID: 9630352
    [Abstract] [Full Text] [Related]

  • 18. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC, Uckert S, Stief CG, Schulz-Knappe P, Hess R, Forssmann WG, Jonas U.
    Urology; 1995 May 15; 45(5):893-901. PubMed ID: 7747383
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
    Netherton SJ, Maurice DH.
    Mol Pharmacol; 2005 Jan 15; 67(1):263-72. PubMed ID: 15475573
    [Abstract] [Full Text] [Related]

  • 20. Implications of PDE4 structure on inhibitor selectivity across PDE families.
    Ke H.
    Int J Impot Res; 2004 Jun 15; 16 Suppl 1():S24-7. PubMed ID: 15224132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.